ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993

Centers Agree To Broader Phase 1 Availability; Cool to Idea Of Distributing Group C Drugs

November 16, 1990

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Prostate Cancer Council Calls For Long-Term Screening Research

September 10, 1993